Related by context. All words. (Click for frequent words.) 68 alpha1 antitrypsin deficiency 68 mGluR2 NAM 68 Epstein Barr Virus EBV 68 indications Dupuytren 68 immuno therapeutic 67 inflammatory demyelinating 67 refractory Hodgkin 67 transgenic rats 67 Monoclonal antibody 67 Chronic lymphocytic leukemia 67 diagnostic biomarker 66 multifactorial disease 66 MELAS 66 acadesine 66 adult mesenchymal stem 66 targeted nucleotide prodrug 66 thetreatment 65 NEUGENE R 65 ATTR CM 65 myeloproliferative neoplasms MPNs 65 psoriasis Crohn disease 65 murine model 65 uricase 65 thalidomide Thalomid 65 potent inducer 65 Familial Adenomatous Polyposis FAP 65 vivo validation 65 mouse xenograft models 65 CYT# potent vascular disrupting 65 vidofludimus 65 antisense inhibitors 65 kidney urologic 65 CMV vaccine 65 Hepatitis C Viral 65 recurrent glioblastoma multiforme 65 Candida infection 64 fibrosarcoma 64 cisplatin resistant 64 optimal dosing regimens 64 mycotic 64 Variant Creutzfeldt Jakob Disease 64 glutamic acid decarboxylase 64 MyVax ® 64 experimentally induced 64 intranasal delivery 64 selectively inhibited 64 isoform selective 64 SNT-MC#/idebenone 64 immuno modulatory 64 pemphigus vulgaris 64 demonstrated antitumor activity 64 chimeric antibody 64 hypereosinophilic syndrome 64 immune modulating 64 Huntingtons disease 64 nucleotide analog 64 polycythemia vera essential thrombocythemia 64 inhibit metastasis 64 novel therapeutic antibodies 64 autosomal dominant polycystic kidney 64 lymphoproliferative disease 64 SSc 64 Nonalcoholic fatty liver 64 XMRV retrovirus 64 receptor inhibitor 64 mediated inhibition 64 antibody mediated 64 ALK inhibitors 64 ANCA associated 64 chronic granulomatous disease 64 Hereditary angioedema 64 chlamydial 64 proliferative disorders 64 arteritis 64 Initiate Clinical Trial 64 Mutation Analysis 64 antiphospholipid syndrome 64 Thiovir 64 idiopathic thrombocytopenic purpura ITP 63 hyaluronidase enzyme 63 allergic airway 63 neovascularisation 63 GW# [003] 63 anaplastic lymphoma kinase ALK 63 patientswith 63 metastatic malignant 63 dasatinib Sprycel 63 Squalamine 63 abacavir Ziagen 63 idiopathic pulmonary 63 enterococcal 63 5 HT4 63 hepatic liver 63 Staphylococcus epidermidis 63 transgenic mouse models 63 topically administered 63 malignant lymphomas 63 immunopathology 63 mda 7 63 gastrointestinal stromal tumors GISTs 63 Alequel 63 ischemia induced 63 enteroviral 63 parasitemia 63 murine models 63 lysosomal storage disease 63 virus HBV 63 novel immunotherapeutic 63 von Hippel Lindau 63 NSAID induced 63 miglustat 63 NPHP 63 Treg cell 63 Gleevec resistant 63 Cotara ® 63 endocrine dysfunction 63 cutaneous lupus 63 melanocortin receptor 63 Kinoid 63 lymphatic vessel 63 BRAF mutant 63 lymphoid tumors 63 pathological hallmarks 63 immunomodulatory properties 63 targeting CD# 63 therapeutic monoclonal antibody 63 primary hyperparathyroidism 63 Alferon N 63 CB2 receptor 63 Neurofibromatosis type 63 Vidaza azacitidine 63 mTOR mammalian target 62 progressive neurodegenerative 62 Epstein Barr virus EBV 62 chronic obstructive airway 62 Ribavirin causes 62 synovial cells 62 PYY #-# 62 helminth 62 genomic biomarker 62 lymphomas leukemias 62 polycythemia vera PV 62 humoral responses 62 cellular immunotherapy 62 adenosine A2A 62 Preclinical Study 62 Personalized Immunotherapy 62 SYN# 62 radiosensitivity 62 HDL Selective Delipidation 62 P#Y# [001] 62 Initiates Clinical Trial 62 Genetic variants 62 node metastasis 62 Myoblast 62 TTR amyloidosis 62 tumorigenicity 62 treat chronic sinusitis 62 Valproic acid 62 thrombo embolic 62 familial hypercholesterolemia FH 62 familial polyposis 62 GRNCM1 62 Fenretinide 62 immunotherapeutic vaccine 62 virulence genes 62 INS# [001] 62 Onconase 62 bullous 62 protein tyrosine phosphatase 1B 62 HLA DR4 62 monogenic 62 essential thrombocythemia ET 62 non nucleoside inhibitor 62 Leukemias 62 motor neuron degeneration 62 bronchoalveolar 62 BRAF V#E mutation 62 Magnesium deficiency 62 PhG alpha 1 62 psoriatic skin 62 G6PD deficiency 62 #beta HSD1 62 epithelial barrier 62 thymosin beta 4 62 mutated K ras 62 Glioblastoma Multiforme 62 biologic pathways 62 vaso occlusive crisis 62 metabolite profiling 62 Immunotherapeutic 62 Trichomonas vaginalis 62 anti PlGF 62 fluconazole resistant 62 anti angiogenic agents 62 bronchial epithelial cells 62 Cytomegalovirus CMV 62 humanized mouse 62 diabetic kidney 62 Associated Diarrhea 62 molecular diagnostic assay 62 Tyrosine Kinase Inhibitor 62 Ph + acute lymphoblastic 62 Factor Receptor 62 RNAi therapeutic targeting 62 HepG2 cells 62 Li Fraumeni 62 immunodeficiency disorders 62 Enzastaurin 62 Panzem 62 PEGylated Fab fragment 62 2DG 62 sarcoid 62 vancomycin resistant 62 ATL# [002] 62 nanoviricides ® 62 humanized monoclonal 62 hemorrhagic cystitis 62 Neugene 61 antibody MAb 61 cells overexpressing 61 fibrogenesis 61 progressive neurodegenerative disorder 61 histone deacetylase inhibitor 61 ADAMTS# 61 Inosine 61 Cytochrome P# 61 Alzheimer Disease AD 61 neurotrophic 61 medically refractory 61 malignant ascites 61 therapeutically useful 61 N. gonorrhoeae 61 RhuDex 61 interstitial cystitis IC 61 pouchitis 61 paraneoplastic 61 benign prostatic hypertrophy BPH 61 DCVax 61 tkRNAi 61 dyskeratosis congenita 61 Factor VIIa 61 Flavivirus 61 Morquio 61 acute lymphoblastic 61 periodontal tissues 61 Janus kinase 61 metastatic uveal melanoma 61 forodesine 61 imexon 61 enkephalin 61 Diarrheal 61 kallikrein 61 systemic mastocytosis 61 SGS# 61 Safinamide 61 Gamunex C 61 anti CD3 antibody 61 potent cytotoxic 61 recurrent glioblastoma multiforme GBM 61 Achieves Primary Endpoint 61 GRN# 61 airway epithelial 61 serotonin uptake 61 interleukin IL -# 61 metabonomics 61 membranous nephropathy 61 airway hyperresponsiveness 61 biomarker assay 61 idiopathic thrombocytopenic purpura 61 neuroinflammatory diseases 61 Interferon beta 61 Trandolapril 61 p# MAP kinase inhibitor 61 Potelligent Technology 61 pulmonary metastasis 61 prognostic biomarkers 61 lichen planus 61 aerosolized KL4 surfactant 61 imatinib resistance 61 lupus scleroderma 61 P. ovale 61 radioimmunotherapy RIT 61 small molecule activators 61 MAGE A3 ASCI 61 chronic eosinophilic leukemia 61 neovascular diseases 61 Sudhir Agrawal D.Phil 61 Tasimelteon 61 telomerase activator 61 malayi 61 midstage clinical 61 vaginal candidiasis 61 extramedullary 61 Osteopontin 61 Glycosylation 61 pancreatic islet 61 intranasal formulation 61 Pyridorin 61 Estrogen Receptor 61 Francisella 61 pancreatic tissue 61 mTOR inhibition 61 oral prodrug 61 p# inhibitor 61 gastroesophageal 61 Opportunistic infections 61 virally induced 61 methicillin susceptible Staphylococcus aureus 61 Interferon Beta 61 Spiegelmer 61 asthma rheumatoid arthritis 61 type 1diabetes 61 mTOR inhibitors 61 ospemifene 61 fibrotic disease 61 NASH Huntington 61 chronic thromboembolic pulmonary 61 Diabetic neuropathy 61 Upregulation 61 neuroblastoma tumors 61 Enterobacter cloacae 61 hibernating myocardium 61 haematological cancers 61 immunotoxins 61 gastro intestinal inflammation 61 Human papillomavirus 61 complement inhibitor eculizumab 61 phenotypic expression 61 AGTR1 61 myeloproliferative disease 61 Virulizin ® 61 receptor blocker 61 BRAF V#E 61 leukocyte adhesion 61 adeno associated viruses 61 psoriasis rheumatoid arthritis 61 Xyfid TM 61 GCase 61 colorectal adenocarcinoma 61 multiple sclerosis psoriasis 61 Dacogen decitabine 61 NOD mouse 61 molecular determinants 61 Aviptadil 61 cMET 61 Smac mimetics 61 LBH# 61 experimental allergic encephalomyelitis 61 debilitating complication 61 Peptide YY 61 thromboembolic disease 61 iPS derived 61 busulfan 61 lucinactant 61 gefitinib Iressa 61 cryptococcosis 61 Angiotensin converting enzyme 61 THR beta agonist 61 Crohns disease 61 colonic motility 61 Trichomonas 61 orally inhaled migraine 61 lymphoid malignancies 61 DGAT1 61 RNAi therapeutic targeting PCSK9 60 Cryptococcus neoformans 60 p# MAPK 60 Vascugel 60 ductal adenocarcinoma 60 NKX#.# 60 DiLA2 liposomes 60 OHR/AVR# 60 systemic RNAi therapeutic 60 Legg Calvé Perthes disease 60 quinacrine 60 Chlamydia psittaci 60 hPTH #-# 60 atypical hemolytic uremic syndrome 60 pentostatin 60 Intra arterial 60 LymphoStat B belimumab 60 included exfoliative dermatitis 60 metastatic neuroendocrine tumors 60 davalintide 60 Candidiasis 60 cyclophilin inhibitors 60 gonococcal 60 TRIM5a 60 immunodeficient 60 systemic amyloidosis 60 CMV infections 60 humanized therapeutic 60 Human cl 60 myelodysplastic myeloproliferative diseases 60 immune modulator 60 HIV coinfected 60 generation purine nucleoside 60 lymphoid organs 60 tryptase 60 selective modulator 60 aurora kinase 60 parthenolide 60 intestinal mucosal 60 siRNA knockdown 60 relapsed ALL 60 renal fibrosis 60 R Saizen R 60 Chronic myeloid leukemia 60 mimetic compounds 60 Cyclosporin 60 Systemic lupus erythematosus SLE 60 Fibroblast 60 fronto temporal dementia 60 Streptococcus pneumoniae serotypes 60 Leydig cell 60 haematologic 60 Vascugel R 60 neuroendocrine cancers 60 Orally administered 60 inflammatory bowel syndrome 60 endothelin receptor 60 JAK2 inhibitor 60 recurrent bladder 60 humanised monoclonal antibody 60 hESC derived cardiomyocytes 60 demethylating agent 60 CHD7 60 targeting PCSK9 60 trastuzumab DM1 T DM1 60 NS#/#A protease 60 5 HT2A serotonin 60 neurona 60 oral Janus kinase 60 containing abacavir 60 simplex virus 60 GVAX ® 60 potently inhibit 60 C. pneumoniae 60 annexin 60 receptor tyrosine kinase inhibitor 60 Associated Adipose Redistribution 60 cetuximab Erbitux 60 chlamydial infections 60 ganaxolone 60 thymidine kinase 60 mGluR5 antagonist 60 Posiphen TM 60 ProMune 60 immune modulatory 60 selective inhibition 60 γδ T cells 60 neuropsychiatric diseases 60 esophageal candidiasis 60 prostaglandin D2 60 prostate carcinomas 60 TransVax ™ 60 fibrocytes 60 lipodystrophy syndrome 60 Lipoic acid 60 Respiratory Syncytial Virus RSV 60 serologic tests 60 generation antisense inhibitor 60 RhuDex R 60 pathophysiological effects 60 DGAT 60 Herpes virus 60 thrombin receptor 60 gastric carcinomas 60 Dosa suffers 60 commercialize deforolimus 60 Genetic mutation 60 Amgen denosumab 60 immunotoxin 60 precancerous condition 60 HepDirect prodrug 60 administered intranasally 60 pancreatic islet cell 60 LAB CGRP 60 edifoligide E2F Decoy 60 Azacitidine 60 Hutchinson Gilford progeria 60 pharmacological chaperone 60 IMiDs ® 60 compound AEZS 60 preclinical pharmacology 60 K ras mutations 60 ABCB1 60 PTHrP 60 Initiates Clinical 60 spongiform encephalopathies 60 Oncolytic 60 Hp2 2 60 CP CPPS 60 pan HDAC inhibitor 60 metastatic colorectal 60 orofacial 60 Begins Dosing 60 gamma secretase inhibitor 60 Opioid induced 60 predictive toxicology 60 coinfection 60 SUVN 60 pneumocystis 60 bladder carcinoma 60 HeFH 60 ESBA# 60 immunoregulatory 60 Omacetaxine 60 Campath alemtuzumab 60 CDDO Im 60 CCR5 mAb 60 bortezomib Velcade 60 Dr. Ivashkiv 60 urothelial cancer 60 plasma kallikrein 60 jejunal 60 neurotrophic factors 60 inhibit enzymes 60 TNF Tumor Necrosis Factor 60 pulmonary metastases 60 molecular pathogenesis 60 subcutaneous immunoglobulin 60 soluble tumor necrosis 60 biotherapy 60 OncoVex 60 metabolomic profiling 60 acetonide FA 60 nephropathic cystinosis 60 infliximab etanercept 60 JAK inhibitors 60 immunocompetent 60 etiologic factors 60 Anavex #-# 60 HER2 neu 60 neurogenic bladder 60 previously undescribed 60 gondii 60 ACV1 60 vitro pharmacology 60 CTAP# Capsules 60 Histoplasmosis 59 herpesviruses 59 ALI ARDS 59 Aliskiren 59 PDE# inhibitors 59 radiolabeled TM# 59 JAK2 inhibitors 59 cystic fibrosis chronic pancreatitis 59 Mucosal 59 HQK 59 bacterium Mycobacterium tuberculosis 59 neuroregenerative 59 EVIZON TM 59 brivanib 59 epigenetic therapies 59 Zalypsis 59 prostate carcinogenesis 59 beta 1a 59 secretagogues 59 LRP5 59 PPAR gamma agonist 59 SCD1 59 periodontal tissue 59 ileitis 59 immunoregulation 59 stratifying patients 59 Plaquenil 59 PAR1 59 PARP inhibition 59 adenovirus infection 59 COX2 59 Presents Preclinical 59 metastatic lymph nodes 59 Fingolimod 59 pylori 59 Hodgkin lymphoma HL 59 HCV protease inhibitors 59 Pseudomonas aeruginosa infections 59 Aplidin 59 Amgen Neulasta R 59 PKC# 59 CDK inhibitor 59 hyperinsulinism 59 LymphoStat B TM 59 Zavesca R 59 PC# cells 59 multikinase inhibitor 59 antitumor immunity 59 myotonic muscular dystrophy 59 vascular disrupting agents 59 Noxafil 59 choroidal vasculopathy 59 e antigen HBeAg 59 Histoplasma capsulatum 59 nasal carriage 59 irreversible inhibitor 59 Prolastin C 59 toenail onychomycosis 59 Vaxfectin TM formulated 59 CCR1 59 Zarnestra 59 myeloproliferative 59 PPARγ 59 ZFP Therapeutics 59 humanized mice 59 DNA intercalator 59 myopathies 59 monocytes macrophages 59 haematopoietic 59 Duchenne muscular dystrophy DMD 59 smoldering myeloma 59 nonbacterial 59 ® lenalidomide 59 ELACYT 59 nonhuman primate models 59 bone morphogenetic proteins BMPs 59 minimally symptomatic 59 Dr. Sosne 59 selective agonist 59 paratuberculosis 59 alpha fetoprotein AFP 59 cartilage regeneration 59 Successfully Completes Phase 59 EGS# 59 SOD1 gene 59 Fabry Disease 59 S. suis 59 Muraglitazar 59 causative genes 59 colorectal carcinoma 59 Beta thalassemia 59 IgM antibody 59 leukoencephalopathy 59 flavopiridol 59 Brodmann Area 59 neuro endocrine 59 denileukin diftitox 59 Evoltra ® 59 cortical stimulation 59 ALB # 59 alveolar epithelial cells 59 rBChE 59 cynomolgus monkeys 59 Beta catenin pathway 59 mycobacterial 59 NS3 protease 59 squamous cell lung cancer 59 obligate intracellular 59 investigational oral hepatitis C 59 invasive lobular 59 polycystic kidneys 59 NF kB pathway 59 pancreatic endocrine 59 interstitial fibrosis 59 inhalation powder 59 pharmacologic therapies 59 bile acid metabolism 59 Vaxfectin formulated 59 FVIII inhibitors 59 Virus HIV 59 breast cancer metastasis 59 Chemotherapy induced 59 Bordetella pertussis 59 LPS induced 59 anti CD3 59 gastrin analogue TT 59 cytotoxic effects 59 etanercept Enbrel 59 Glioblastoma Multiforme GBM 59 ANGPTL4 59 Abbott ARCHITECT 59 CD8 + cytotoxic 59 SIADH 59 Glioblastoma multiforme GBM 59 bacterium Listeria 59 coronary artery atherosclerosis 59 Retinoic Acid 59 acid phosphatase PAP 59 VitiGam 59 Antiangiogenic 59 Initiates Phase II 59 vapreotide acetate 59 lenalidomide dexamethasone 59 severe malignant osteopetrosis 59 virus AAV 59 Corynebacterium 59 experimental autoimmune encephalomyelitis 59 Thymosin beta 4 59 Genetic susceptibility 59 S. maltophilia 59 Aflibercept 59 motilin 59 transthyretin 59 hypokalemia hypomagnesemia 59 shingles herpes zoster 59 osteopontin OPN 59 anti infective treatments 59 FGFs 59 NSCLC tumors 59 liposomal amphotericin B 59 Aurora Kinase 59 Angiotensin Therapeutic Vaccine 59 EGFR blockers 59 lymphocytic choriomeningitis virus LCMV 59 clevidipine 59 gastric adenocarcinoma 59 pathogenic mechanisms 59 elastase 59 adenoviral vectors 59 P#X# 59 basal cell nevus syndrome 59 inherited retinal 59 pharmacological inhibition 59 hemoglobinopathies 59 FUSILEV enhances 59 PEGylated anti 59 TTR gene 59 oxysterols 59 immune dysregulation 59 erythema nodosum 59 intracellular bacteria 59 synthase TS 59 antiproliferative effects 59 sporadic Creutzfeldt Jakob 59 reverse vaccinology 59 griseofulvin 59 Bosutinib 59 organogenesis 59 linezolid resistant 59 androgen receptor AR 59 acamprosate prodrug 59 discoid lupus 59 adecatumumab MT# 59 pegylated recombinant 59 induced anemia 59 Fc receptor 59 facioscapulohumeral muscular dystrophy 59 rhIGF-I/rhIGFBP-3 59 imatinib Gleevec 59 infantile NCL 59 receptor PPAR 59 neuro degenerative 59 ductal carcinomas 59 systemically administered 59 SUFFERERS 59 Creutzfeld Jakob disease 59 Reports Preclinical Data 59 Fatty liver 59 cSSSIs 59 BrachySil ™ 59 ERalpha 59 neuronal nitric oxide synthase 59 CCR3 59 breast endometrial 59 drug GAP #B# 59 Neogenix 59 ChronVac C R 59 DNA methylation patterns 59 Adenoviral 59 Epratuzumab 59 thiazolides 59 Vaxfectin R formulated 59 Staphylococcus aureus infections 59 HuMax TAC 59 predisposing factor 59 idiopathic PAH 59 Wnt signaling pathway 59 branching morphogenesis 59 depsipeptide 59 Jakob Disease 59 c myc gene 59 Phase 2b Clinical Trial 59 PI3K/Akt pathway inhibitor 59 Degarelix 59 retinal degenerative disease 59 MyVax R 59 neuronal dysfunction 59 selective antagonist 59 immunoblot 59 NIC5 58 Trodusquemine 58 streptococcus pneumonia 58 Vitaxin 58 Histone deacetylase 58 gp# protein [002] 58 ADME properties 58 luciferase gene 58 itraconazole Sporanox 58 targeted radiotherapeutic 58 invasive fungal 58 functional polymorphism 58 ADPKD 58 dysgenesis 58 acetylcholine receptor 58 vimentin 58 mastocytosis 58 lupus multiple sclerosis 58 AGHD 58 Neuroprotection 58 DNA methyltransferases 58 cilengitide 58 ADAM# 58 NF kB Decoy 58 immunologic responses 58 mimetics 58 Compellis 58 neuroactive 58 TRO# 58 anticancer therapeutics 58 XYOTAX TM 58 Archexin 58 Nipent R 58 Belerofon 58 capsular polysaccharide 58 Lichen planus 58 Enterobacter 58 reproductive endocrine 58 NV1FGF 58 lymphatic vasculature 58 hypocalcaemia 58 antitumour 58 leukemia lymphomas 58 integrin inhibitor 58 Elagolix 58 Tr DNA 58 cardiac repolarization 58 combination antiretroviral therapy 58 synaptogenesis 58 protein misfolding diseases 58 redox active 58 valvular heart disease 58 astemizole 58 post transplant lymphoproliferative 58 potent antiproliferative 58 Edward Lanphier Sangamo 58 axonal degeneration 58 sickle cell hemoglobin 58 hypothalamic pituitary 58 XL# inhibits 58 tramiprosate Alzhemed TM 58 vectored vaccine 58 AML acute myeloid 58 HuCNS SC ® 58 small molecule activator 58 non nucleoside 58 S. neurona 58 cytomegalovirus retinitis 58 trans retinoic acid 58 neoplastic diseases 58 Progressive Multifocal Leukoencephalopathy 58 mertansine 58 Trichophyton rubrum 58 riociguat 58 alicaforsen 58 invasive candidiasis 58 tipifarnib 58 molecular biomarkers 58 AKT inhibitor 58 multicenter Phase II 58 infused intravenously 58 idiopathic membranous nephropathy 58 myeloproliferative diseases 58 Tarvacin Anti Viral 58 antiapoptotic 58 immune globulin intravenous 58 Delayed Graft Function 58 hepatic toxicity 58 Enkephalin 58 romazarit 58 UVB induced 58 oropharyngeal candidiasis OPC 58 Varicella zoster virus 58 fibrin deposition 58 gastro oesophageal reflux 58 bronchodilatory 58 Photodynamic therapy PDT 58 Parkinson disease levodopa induced 58 antifibrotic 58 Hemorrhagic 58 biased ligand 58 evaluating tivozanib 58 brucei 58 Dendritic cell 58 Transdermal Patch 58 Anaplasmosis 58 Saccharomyces boulardii 58 colony stimulating factors 58 intravenous immunoglobulin IVIg 58 Cimzia TM 58 brivaracetam 58 AEG# 58 Darapladib 58 pan genotypic 58 pregabalin Lyrica 58 cathepsin K 58 preclinical efficacy 58 abnormal angiogenesis 58 purified recombinant 58 IL# PE#QQR 58 IAP inhibitors 58 MGd 58 Temsirolimus 58 antiangiogenesis 58 replicase 58 novel VDA molecule 58 arterial calcification 58 kinase pathway 58 Glucocorticoid 58 gastrointestinal dysfunction 58 oncomodulin 58 hypothalamic pituitary adrenal axis 58 Genentech Rituxan 58 oral salmon calcitonin 58 cannabinor 58 gastrointestinal stromal tumors GIST 58 Dysregulation 58 underlying pathophysiology 58 amyloid toxicity 58 potent stimulator 58 Aggrastat ® tirofiban hydrochloride 58 antisense inhibitor 58 Vesivirus 58 huC# DM4 58 neuroinflammation 58 cancerdefine 58 inhibiting enzymes 58 hepatobiliary 58 Daclizumab 58 Cogane 58 inhibitor RG# 58 inverse agonist 58 replicon 58 mTOR signaling pathway 58 Umbilical cord stem cells 58 neurological manifestations 58 oral ghrelin agonist 58 Vidaza ® 58 TÎ ² 4 58 ocular disorders 58 YONDELIS R 58 Src kinase 58 Neuropeptide Y 58 selective adenosine 58 Apatone 58 E. faecalis 58 IAP inhibitor 58 Cancidas 58 Systemic lupus erythematosus 58 Ataluren 58 oral thrush 58 LCMV infection 58 Chronic Lymphocytic Leukemia CLL 58 Candida species 58 HIF 1α 58 Chronic pancreatitis 58 adipose derived regenerative 58 Genentech Biogen 58 discontinued Viread 58 highly selective inhibitor 58 neuro degenerative disorders 58 lung fibrosis 58 antitumor effect 58 P. gingivalis 58 GPI anchored 58 C1INH 58 enteroviral infection 58 mitogen activated protein kinases 58 Tß4 58 Velcade bortezomib 58 arterial inflammation 58 rheumatologic 58 Intravitreal 58 thromboxane A2 58 Herpes zoster 58 radezolid 58 immunomodulatory effects 58 chromium supplementation 58 transdifferentiation 58 Cytotoxic 58 potently inhibited 58 leptin deficiency 58 eTag assays 58 Pim kinases 58 diabetic gastroparesis 58 multisystem disease 58 virosome 58 benzimidazole 58 carcinoid 58 metabolic disturbances 58 Vidaza R 58 chemokine receptors 58 attach auristatin 58 targeted antifolate 58 herpes encephalitis 58 antimitotic 58 JAK2 enzyme 58 non resectable metastatic 58 RSV replication